Literature DB >> 17885552

Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients.

Matteo Pirro1, Giuseppe Schillaci, Cinzia Menecali, Francesco Bagaglia, Rita Paltriccia, Gaetano Vaudo, Massimo R Mannarino, Elmo Mannarino.   

Abstract

OBJECTIVE: Circulating endothelial progenitor cells (EPCs) differentiate into mature endothelial cells and regenerate the injured endothelium. The role of homeobox A9 (HOXA9) is critical for endothelial commitment during progenitor cell maturation, postnatal neovascularization and vascular repair. The objective of our study was to measure the expression of HOXA9 in CD34+ cells from hypertensive patients and to investigate its correlation with the number of circulating EPCs.
METHODS: Thirty patients with newly diagnosed, never-treated essential hypertension and 30 age- and sex-matched normotensive controls were recruited for the study. Total RNA was extracted from peripheral CD34+ cells and quantitative real-time polymerase chain reaction for measurement of HOXA9 expression was performed. The number of CD34+/human kinase insert domain protein receptor + (KDR+) EPCs was measured and the Framingham risk estimated.
RESULTS: Hypertensive patients had reduced HOXA9 expression compared to normotensive subjects (-26%, P < 0.001), and lower levels of peripheral CD34+/KDR+ EPCs (421 +/- 93 versus 582 +/- 101, P < 0.001). HOXA9 expression was inversely associated with systolic blood pressure (r = -0.54, P < 0.001) and the Framingham risk (r = -0.50, P < 0.001). A direct association was observed between the number of EPCs and HOXA9 expression (r = 0.50, P < 0.001), which was independent of blood pressure levels and Framingham risk. In a subgroup of 15 hypertensive patients, a 4-week treatment with ramipril was associated with a significant 15% increase in HOXA9 expression and 25% increase in EPC levels.
CONCLUSIONS: In hypertensive patients, downregulation of HOXA9 expression in peripheral CD34+ cells may have a role in the loss of circulating EPCs, thus potentially impairing postnatal neovascularization and vascular repair.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885552     DOI: 10.1097/HJH.0b013e32828e506d

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  30 in total

1.  Transcriptional profiling of CD133(+) cells in coronary artery disease and effects of exercise on gene expression.

Authors:  Delong Liu; Alexander P Glaser; Sushmitha Patibandla; Arnon Blum; Peter J Munson; J Philip McCoy; Nalini Raghavachari; Richard O Cannon
Journal:  Cytotherapy       Date:  2011-02       Impact factor: 5.414

Review 2.  Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!

Authors:  C V Borlongan
Journal:  Leukemia       Date:  2011-07-05       Impact factor: 11.528

3.  Cord blood-circulating endothelial progenitors for treatment of vascular diseases.

Authors:  M Lavergne; V Vanneaux; C Delmau; E Gluckman; I Rodde-Astier; J Larghero; G Uzan
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 4.  Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

Authors:  Gian Paolo Fadini; Douglas Losordo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2012-02-17       Impact factor: 17.367

Review 5.  Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent.

Authors:  Johannes C Grisar; Francois Haddad; Fatemeh A Gomari; Joseph C Wu
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

6.  Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism.

Authors:  C De Ciuceis; A Pilu; C Cappelli; E Porteri; F Zani; A Santoro; E Gandossi; G E M Boari; N Rizzardi; M Castellano; D Rizzoni; E Agabiti Rosei
Journal:  J Endocrinol Invest       Date:  2010-06-28       Impact factor: 4.256

7.  Bone marrow transplantation improves endothelial function in hypertensive Dahl salt-sensitive rats.

Authors:  Hong Yu; Hongwei Shao; Jing Yan; Nikolaos M Tsoukias; Ming-Sheng Zhou
Journal:  J Am Soc Hypertens       Date:  2012 Sep-Oct

8.  Stem Cells for Neurovascular Repair in Stroke.

Authors:  Kazutaka Shinozuka; Travis Dailey; Naoki Tajiri; Hiroto Ishikawa; Dae Won Kim; Mibel Pabon; Sandra Acosta; Yuji Kaneko; Cesar V Borlongan
Journal:  J Stem Cell Res Ther       Date:  2013-05-01

9.  Quantitative and functional characteristics of endothelial progenitor cells in newly diagnosed hypertensive patients.

Authors:  M Skrzypkowska; J Myśliwska; B Słomiński; J Siebert; P Gutknecht; M Ryba-Stanisławowska
Journal:  J Hum Hypertens       Date:  2014-10-09       Impact factor: 3.012

Review 10.  Aging and disease as modifiers of efficacy of cell therapy.

Authors:  Stefanie Dimmeler; Annarosa Leri
Journal:  Circ Res       Date:  2008-06-06       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.